Evidence map›Paper›PMID 38662084›Full record

ArticleParasitology research2024

Anti-Anisakis antibodies in colon cancer patients and their relationship with γδ T-cells.

Juan C Andreu-Ballester, Carmen Cuéllar, Javier Colmena-Zaragoza, Lorena Galindo-Regal, Carolina Hurtado-Marcos, Juan González-Fernández, Zutoia Balciscueta, Carlos García-Ballesteros, Francisca López-Chuliá, Ana I Jiménez and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Parasitology research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Experimental pathogenicity ofFood and waterborne parasitology · 2026
    Article
  2. Anisakiasis: A Decade of Molecular and Diagnostic Advancements (2015-2026).International journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Juan C Andreu-Ballester *FISABIO Foundation-Public Health of Valencia, Spain and Parasitic Immunobiology and Immunomodulation Research Group (INMUNOPAR), Complutense University of Madrid, Madrid, Spain.
Carmen Cuéllar *Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040, Madrid, Spain. cuellarh@ucm.es.ORCID https://orcid.org/0000-0001-7948-9889
Javier Colmena-ZaragozaEmergency Medical Assistance Service (SAMU), Valencia, Spain.
Lorena Galindo-RegalLaboratory of Molecular Biology, Arnau de Vilanova Hospital, Valencia, Spain.
Carolina Hurtado-MarcosLaboratory of Parasitology and Immunology, San Pablo CEU University, Madrid, Spain.
Juan González-FernándezDepartamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040, Madrid, Spain.
Zutoia BalciscuetaSurgery Department, Arnau de Vilanova Hospital, Valencia, Spain.
Carlos García-BallesterosHematology Department, Arnau de Vilanova Hospital, Valencia, Spain.
Francisca López-ChuliáHematology Department, Arnau de Vilanova Hospital, Valencia, Spain.
Ana I JiménezPathology Department, Arnau de Vilanova Hospital, Valencia, Spain.
Antonio Llombart-CussacDepartment of Medical Oncology in Arnau de Vilanova Hospital, Valencia, Spain.
Hospital Arnau de Vilanova · ESUniversidad Complutense de Madrid · ESUniversidad San Pablo CEU · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many pathogens are related to carcinogenesis. Chronic inflammation, as a result of persistent infection, leads to DNA damage, higher expression of oncogenes, decreased apoptosis and immunosuppression, which are some of the reasons for cancer induction. Among parasites, Schistosoma, Opistorchis and Clonorchis are recognised as infectious agents which contribute to cancer. A relationship between Anisakis and cancer was hypothesised because cellular responses to Anisakis products could result in inflammation and DNA damage. Previous research has shown a decrease in CD8+ γδ T-cells and an increase in αβ and γδ T-cell apoptosis in colon cancer (CC) samples. Ninety-two CC patients and 60 healthy subjects were recruited. γδ and αβ T-cells were analysed, and their apoptosis was evaluated. Anti-Anisakis antibodies were tested in sera from CC patients and controls. Anti-Anisakis IgG, IgM, IgA and IgE antibodies were significantly higher in CC patients. A significant increase in anti-Anisakis IgA levels was observed in patients with angiolymphatic invasion. The number of all γδ T-cells, as well as CD3+ CD4+ αβ T-cells, was significantly lower in CC patients. The apoptosis of all T-cells was significantly increased in patients with CC. We observed a significantly higher percentage of anti-Anisakis IgE positive patients having a deficit of CD3+ γδ T-cells. Our results suggest a relationship between Anisakis and CC.

Indexed as

AnisakisAntibodies, HelminthColonic NeoplasmsAdultAgedAged, 80 and overAnimalsApoptosisFemaleHumansMaleMiddle AgedReceptors, Antigen, T-Cell, gamma-deltaT-LymphocytesT-Lymphocyte SubsetsAntibodies, HelminthReceptors, Antigen, T-Cell, gamma-deltaAnisakisApoptosisColon cancerSpecific antibodiesαβ T-cellsγδ T-cells

Identifiers

PMID38662084
PMCPMC11045616
OpenAlexW4395466489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.